Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.335 AUD | 0.00% | 0.00% | +63.41% |
May. 01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
Apr. 22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+63.41% | 121M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix : Secures Ethics, Regulatory Approval for Phase 3 Kidney Disease Trial in Australia